Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

TriSalus Life Sciences (TLSI) Cost of Revenue (2022 - 2026)

TriSalus Life Sciences has reported Cost of Revenue over the past 5 years, most recently at $7.4 million for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 395.85% year-over-year to $7.4 million; the TTM value through Mar 2026 reached $12.9 million, down 16.95%, while the annual FY2025 figure was $7.0 million, 73.04% down from the prior year.
  • Cost of Revenue for Q1 2026 was $7.4 million at TriSalus Life Sciences, up from $1.8 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $7.4 million in Q1 2026 and troughed at -$6.6 million in Q4 2022.
  • A 5-year average of $1.9 million and a median of $1.5 million in 2025 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: plummeted 80.56% in 2023 and later surged 1104.47% in 2024.
  • Year by year, Cost of Revenue stood at -$6.6 million in 2022, then soared by 108.79% to $582000.0 in 2023, then surged by 1104.47% to $7.0 million in 2024, then tumbled by 74.86% to $1.8 million in 2025, then surged by 320.72% to $7.4 million in 2026.
  • Business Quant data shows Cost of Revenue for TLSI at $7.4 million in Q1 2026, $1.8 million in Q4 2025, and $1.9 million in Q3 2025.